《西维斯健康CVS Health（CVS）：健康2030：2024年社会影响报告「NYSE」（英文版）（98页）.pdf》由会员分享，可在线阅读，更多相关《西维斯健康CVS Health（CVS）：健康2030：2024年社会影响报告「NYSE」（英文版）（98页）.pdf（98页珍藏版）》请在三个皮匠报告上搜索。

1、Healthy 20302024 Impact ReportAppendixTable of Contents 030408 091215172835 40426073Corporate ProfileHealthy 2030 Impact Strategy&GovernanceImpact Strategy Prioritization AssessmentStakeholder EngagementUnited Nations Sustainable Development GoalsTracking Our ProgressHuman Capital DataOur Commitment

2、 to Human RightsEnvironmental Data IndicesAbout this ReportGlobal Reporting Initiative(GRI)IndexSustainability Accounting Standards Board(SASB)IndexClimate Disclosure2Corporate ProfileOrganizational DetailsOur Strategy:Building a world of health around every consumerOur Locations9,000+retail locatio

3、ns1,000+walk-in and primary care medical clinics36M+Aetna members85%of the U.S.population lives within 10 miles of a CVS location90M+Members and patients ofCVS HealthspireEconomic ImpactFinancial Results and Economic Impact:Our employees earned$17.9B in wages and$2.5B in benefits$372.8B in total rev

4、enues$6.3B to providers of capital$3.7Bin income,property and employer taxes in the U.S.CVS Health Corporation Public Corporation(NYSE:CVS)Headquartered in Woonsocket,RI Operates in the United States in 50 states plus the District of Columbia and Puerto Rico More than 300,000 ColleaguesNext Section3

5、Table of ContentsHealthy 2030 Impact Strategy&GovernanceOur Healthy 2030 impact strategy outlines how we are creating a more equitable health care system and sustainable future.It reinforces our companys strategy and is embedded in our purpose-driven culture.This strategy centers on our material top

6、ics and aligns with the Global Reporting Initiative(GRI)Standards.Healthy 2030 is constructed through our four-pillar framework Healthy People,Healthy Business,Healthy Community and Healthy Planet.We are focused on making a meaningful,measurable impact within each of these pillars.Our Board of Direc

7、tors and our President and Chief Executive Officer(CEO)lead governance of our Healthy 2030 framework.The Nominating and Corporate Governance Committee of the Board of Directors is formally charged with over sight of impact strategy and performance,along with our President and Chief Executive Officer

8、.Our Chief Sustainability Officer(CSO)shares relevant impact-related impacts,risks and opportunities with the Nominating and Corporate Governance Committee semiannually,and the full Board annually.Additionally,the Nominating and Corporate Governance Committee reviews our annual Impact report.In 2024

9、,the Nominating and Corporate Governance Committee was engaged on several key topics,including:Climate change reporting and risks Progress toward achieving emissions reduction targets,including net-zero targets Sustainability initiatives across plastic,paper,waste,and other resource reduction Renewa

10、ble energy procurement Philanthropic programs and investments Human capital mattersThe Committee assesses how to oversee new initiatives through action and approval.Our CSO is responsible for developing our impact strategy and ensuring we progress against our goals.Under this direction,the Corporate

11、 Social Responsibility(CSR)&Philanthropy team regularly works with enterprise leaders to align our strategy with key business imperatives,and collaborates with colleagues throughout the company on programs and initiatives that drive social and environmental impact.Our cross-functional Steering Commi

12、ttee is charged with advancing impact initiatives and progress to achieving our Healthy 2030 goals.The Steering Committee is comprised of senior leaders across the company at the vice president level and above,including representatives from human resources,legal and finance,as well as each of our bu

13、siness segments.These leaders and their teams are responsible for executing the day-to-day initiatives driving our progress.Through our Healthy 2030 strategy,we have established several policies that govern our approach to issues of importance to our business and our stakeholders.Topics addressed in

14、clude climate change,deforestation,human rights,and chemical management,all of which are located in our online Resource Library.These policies are reviewed and updated regularly.Next Section4Table of ContentsTo advance our Healthy 2030 strategy,we have identified key colleagues and business leaders

15、with direct oversight of initiatives that will help us achieve our goals.These colleagues are responsible for driving performance and meeting established targets as part of their business plans and annual goals.This includes members of our Steering Committee and their teams,and key senior leaders.Th

16、e remuneration of these colleagues is partially linked to performance against these business plans.In 2024,we evolved our workforce modifier to reflect a broader company culture metric and a more comprehensive measure of engagement and belonging,using colleague engagement survey results,and actions

17、that reinforce CVS Health as an employer of choice for our colleagues while reinforcing leadership accountability.Progress will be measured based on the results of colleague engagement surveys,with a goal to maintain or improve scores over the year.Learn more in our annual Proxy.RemunerationHealthy

18、2030 Impact Strategy&GovernanceNext Section5Table of ContentsHealthy 2030 Impact Strategy&GovernanceHealthy 2030 supports the advancement of our roadmap in four key areas:Healthy PeopleWe are building a world of health around every individual.We connect people to the care they need,put medicine and

19、wellness within reach and drive greater affordability,simplicity,and convenience in everything we do.Whether we are increasing access to health care and services or making investments to support our communities to improve health outcomes,we are utilizing our expertise and resources to improve people

20、s health.Healthy BusinessWe are purpose-driven all of us.We have an opportunity to harness the power of our greatest strength-our talented and diverse workforce of more than 300,000 colleagues-to reimagine health care in America and create a more equitable and inclusive future for all.Together,we se

21、t high standards and hold ourselves to them.We work daily to create value for everyone who trusts and relies on us and ensure every action we take is done ethically and transparently.We support our colleagues education and growth with scholarships,promote and develop leadership skills through traini

22、ng and development courses and continue strengthening our pipeline to expand our workforce through job training and skill building programs in our communities.We integrate governance and partnership across our business units.Next Section6Table of ContentsHealthy CommunityWe are strengthening our com

23、munities by addressing the unique barriers to improving health outcomes locally.We support organizations centering their work on heart health,mental health,womens health,healthy aging and climate-related health impacts.We also invest in the resources needed for communities to take proactive steps to

24、ward a healthier future.This includes addressing food insecurity,improving access to workforce training and educational opportunities nationwide.When a natural disaster or other incident affects the communities where we live and work,we swiftly take action to ensure our response addresses our collea

25、gues and customers evolving needs.Our colleagues are also making a difference by donating their time and talents with organizations that are meaningful to them.Together,we make a lasting impact by driving a holistic approach and collaboration across these community programs,investments and organizat

26、ions.Healthy PlanetWe recognize that the health of the planet affects human health and our access to health care and nutritious food-from the impacts of extreme weather,to air and water quality,to the mental health and medicinal benefits from biodiversity and nature.We continue to invest in initiati

27、ves and programs that focus on improving the health of our planet by advancing our sustainability commitments and addressing the environmental factors that contribute to health inequities.We were one of the first companies in the world to have our net-zero targets validated by the Science-Based Targ

28、ets Initiatives(SBTi)net-zero methodology.We continue to reduce greenhouse gas emissions and source renewable energy on the path to achieving net-zero emissions across our value chain by 2050.We also drive packaging innovation and efforts to reduce unnecessary plastics and waste across the enterpris

29、e.Healthy 2030 Impact Strategy&GovernanceNext Section7Table of ContentsImpact Strategy Prioritization Assessment In 2023,we completed an assessment to identify the sustainability topics most important to our business and ensure their integration in our Healthy 2030 strategy.This work was done in col

30、laboration with sustainable business network and consultancy BSR and aligns with leading reporting standards and frameworks.This assessment represented a shift to an impact-based approach,measuring potential and actual impacts of sustainability topics.It assessed the severity of potential impact on

31、enterprise value,society and the environment,as well as the likelihood of the impact to occur.Our Healthy 2030 strategy is continuously evolving.This assessment demonstrates our iterative approach to refining and strengthening our programming and initiatives.We continue to monitor reporting framewor

32、ks and guidance.More can be found in our reporting boundaries.Learn more about results of our assessment from 2023Prioritizing impact in our Healthy 2030 strategy*Next Section*FOR IMPACT STRATEGY:Our priority topics reference which economic,environmental,social and governance issues are most impactf

33、ul to our stakeholders and our business.The inclusion of topics in this assessment and the inclusion of information in this report generally should not be construed as a characterization regarding its materiality or significance for any other purpose,including for purposes of applicable securities l

34、aws.8Table of ContentsStakeholder EngagementAdvancing our Healthy 2030 roadmap and achieving our goals requires the input and collaboration of a diverse set of external and internal stakeholders.We maintain regular,open communication with a broad range of stakeholders who share our commitments to su

35、pport the health of all we serve.The feedback provided by our stakeholders is integral to advancing our strategy and the initiatives we drive to achieve our goals.We establish a two-way dialog with advocates,policymakers,shareholders,customers,colleagues,partners and patients.2024 Engagement Highlig

36、hts Through our membership in the CDP Supply Chain program,we collect supplier emission data and work with key suppliers for highest impact.To further reduce our carbon footprint,we have implemented several initiatives in collaboration with USPS,including the use of their recommended recyclable pack

37、aging,keeping delivery as local as possible,and standardizing 2024 addresses.Approximately 97%of our USPS prescription deliveriesrepresenting more than half of all deliveries from retail locationsare made within a 50-mile radius from origin to destination.Launched phase 2 of the Consortium to Reinve

38、nt the Retail Bag.Conducted an investor perception study with S&P Global to understand how investors utilize our Impact Report and related assets to inform our 2024 approach.Provided$1.5 million to support communities impacted by natural disasters.92024 Engagement HighlightsNext Section9Table of Con

39、tentsStakeholderEngagementStakeholder GroupStakeholder Engagement ChannelsPatients and consumers In-person interactions Telehealth appointments Virtual consultations Focus groups Customer relations inquiries Surveys Social media Websites Mail/emailColleagues Meetings and interviews with leaders and

40、business owners Engagement surveys Training and professional development opportunities CVS Health intranet Colleague Resource Groups(CRGs)virtual and in-person meetings Town Hall meetings On-going memos from leadership with enterprise updates Company websiteInvestors and stockholders Annual stockhol

41、ders meeting Quarterly earnings calls Virtual meetings Email correspondence Responses to ratings and rankings Conferences Surveys and data requests WebsiteSuppliers Meetings Email/mail communications Industry/collaborative associations Conferences and events Factory audits Human Rights Policy Code o

42、f Conduct Training and workshops Surveys and auditsStakeholder groups and engagement types:Next Section10Table of ContentsGovernment and regulators Briefings and meetings Phone briefings Email correspondence White papers and other briefing materials Trade organizations Participation in coalitions Ro

43、undtable discussions Public events Sponsorship of events Speaking engagements Media engagementsNonprofit organizations and NGOs Roundtables Strategic relationships Participation on boards and advisory councils Attending annual meetings Virtual engagement meetings Webinars Surveys Thought leadershipI

44、ndustry groups and forums Conferences Virtual meetings Strategic relationships Pilot/initiative collaboration SurveysLocal communities Community engagement programs Volunteerism Board memberships Event sponsorship Grantmaking Small and diverse supplier engagement and economic development Workforce d

45、evelopment and job training programs Community development and investment programsClients Meetings Phone and email correspondence Surveys Disclosure requests Meetings and conferencesMedia Direct outreach Website Social media Responses to inquiries Interviews,roundtables and/or panels ConferencesStak

46、eholderEngagementStakeholder groups and engagement types:Cont.Next Section11Table of ContentsUnited Nations(UN)Sustainable Development GoalsOur Healthy 2030 strategy is aligned with the United Nations Sustainable Development Goals(SDGs),which are 17 aspirational goals designed to facilitate signific

47、ant global development by 2030.The SDGs serve as a framework to guide how companies,governments and non-governmental organizations contribute to a more just,healthier and sustainable future.We believe we can most meaningfully contribute to eight SDGs that closely align with our business impact.We wo

48、rk to advance these goals each year through efforts implemented across our enterprise.To further our progress,we collaborate with organizations that help us advance our Healthy 2030 strategy including the United Nations Global Compact(UNGC).CVS Health was the first U.S.pharmacy chain to hold members

49、hip in the UNGC,which confirms our commitment to the Compacts ten Principles with respect to human rights,labor,the environment and anti-corruption.SDGs OverviewGoal 2:Zero Hunger The food we eat impacts our health at every stage of life.Healthy eating can lower the risk of chronic disease,boost imm

50、unity,and extend life expectancy,among other benefits.But today,nutrition-related diseases are contributing to rising health care costs.And for many people who need them,medically-tailored nutrition remains out of reach.Were working to address these challenges with multi-year commitments designed to

51、 support those facing food insecurity and increase access to fresh,healthy food in communities we serve.In 2024,we granted nearly$1.5 million to support nonprofit organizations working to address food insecurity in their communities.Learn more about how were supporting food insecurity.Goal 3:Good He

52、alth and Well-Being We continue to expand on our ability to provide care and fundamentally restructure how health care is delivered in the U.S.how,by whom and where.With touchpoints throughout a persons health journey,we support patients and members with interventions,early diagnosis and treatment o

53、ptimization.The results are improved health outcomes,lower costs,more durable relationships with providers,and broader access to high-quality care.Learn more about how were improving outcomes.Next Section12Table of ContentsGoal 4:Quality Education We continue to invest in developing diverse workforc

54、e to support the needs of under-resourced communities.Our scholarship programs support students working toward pharmacy,clinical practice and retail management degrees across higher education institutions in the U.S.In 2024,we awarded over$1 million in scholarship funding to students pursuing academ

55、ic programs in Pharmacy,Nursing,and Retail Management.Learn more about how were investing in the future healthcare workforce.Goal 5:Gender Equality On our journey to provide personalized,high-quality and convenient care to all,we understand that womens health needs are unique.Thats why we are provid

56、ing access to services and resources to help women better understand and navigate their health.We are prioritizing health conditions that are exclusively disproportionally or differentially experienced by women behavioral,reproductive,maternal and heart health,menopause and healthy aging.Our workfor

57、ce comprises 70%women,including 57%at the manager level and above.Goal 8:Decent Work and Economic Growth We are delivering on our bold vision for health care delivery with an incomparable set of assets that are uniquely CVS Health.The greatest of these strengths is our workforce of more than 300,000

58、 purpose-driven colleagues.In 2024,we invested in their growth,provided them with comprehensive benefits and implemented new policies to improve their workplace experience.We also hired more than 110,000 new colleagues,paid out$17.9 billion in wages;$2.5 billion in benefits;and$3.7 billion in income

59、,property and employer taxes in the U.S.We invested$3.2 billion in small businesses across the U.S.in 2024.Goal 12:Responsible Consumption and Production A growing plastic waste crisis significantly impacts human health through the air we breathe,the water we drink and the food we eat.At the same ti

60、me,plastic is an incredibly valuable material for safe health care delivery and product quality.We believe we have an important role in solving this challenge through external industry collaboration and thoughtful strategy in addressing non-essential,single-use plastic.Most of our plastic usage by w

61、eight comes from our mail order/specialty packaging,store brand packaging,prescription bottles and plastic bags.In 2024,we worked to eliminate or use less plastic where we can;replaced plastic with alternative materials;identified end-of-life solutions that increase recyclability;and encouraged cust

62、omers to join us in our efforts.Learn more about our sustainable materials strategy.United Nations(UN)Sustainable Development GoalsNext Section13Table of ContentsGoal 13:Climate ActionWe are working to achieve carbon neutrality by 2030 and net-zero emissions across our value chain by 2050 a commitme

63、nt that will require collaboration,innovation and drive.Our path forward will focus on significant investments in renewable energy,electrification of our fleet,and continuous improvement in operational efficiency.We continue to enhance our collaboration with suppliers,ensuring that they set their ow

64、n science-based emissions reduction targets and take steps to reduce their emissions accordingly.Learn more about how were supporting environmental health.Goal 15:Life on LandOur efforts to transform the health of our planet include reducing our consumption of natural resources.All palm oil used in

65、our store brand products is sourced sustainably by our suppliers in compliance with our Responsible Palm Oil Policy.To continue to reduce the impacts of our operations,we are investing in digital tools and solutions to reduce our paper usage,including through receipts at CVS Pharmacy.Learn more abou

66、t how were supporting environmental health.United Nations(UN)Sustainable Development GoalsNext Section14Table of ContentsTracking our ProgressTargetTarget Year2024 ProgressStatusExecute SBTi-validated net-zero target by reducing absolute scope 1,2&3 emissions by 47%2030 28%reduction in scope 1 and 2

67、 GHG emissions from 2019 baseline and 13%decrease from 2023-2024.58%reduction in scope 3,category 1(PGS)GHG emissions from 2019 baseline and 8%increase from 2023-2024.In progressSource 50%of our energy from renewable sources2040 Executed agreements to source over 100k MWh of renewable energy in 2024

68、.*Total executed agreements to-date represent more than 969,200 MWh of renewable energy.102K MWh of renewable energy utilized in 2024.*Progress measured from 2024 electric consumption of 1.85M MWh;50%target equates to roughly 0.94M MWh.In progressAchieve 100%carbon neutrality for scopes 1&22030We co

69、ntinue to make progress in reducing scope 1 and 2 emissions in line with our science-based target.In progressAdvance strategies to reduce plastic usage by 50%across operations2030 2023:34,741.32 MT 2024:31,420.71 MT 9.6%decrease from 2023In progressEnsure Store Brand packaging is 100%reusable,recycl

70、able,or compostable2030As of December 31,2024,45.5%of store brand product components are designated as reusable,recyclable*or compostable.*We use How2Recycles designations of widely recyclable and store drop offs to define“recyclable.”In progressWe have set ambitious goals and are holding ourselves

71、accountable to drive impact towards our Healthy 2030 strategy.Key initiatives driving progress to these goals are highlighted in Healthy Planet.Next Section15Table of ContentsTracking our ProgressReduce virgin plastic in Store Brand packaging by 50%2030 In 2023,5%of our products made with plastic co

72、ntained recycled content.In 2024,5%of our products made with plastic contained recycled content.We still have considerable progress to make and investments made in 2024 to data collection and assessment tools will help us evaluate and drive progress.We continue to evaluate how to best report on this

73、 goal and capture efforts with a continuously evolving product portfolio and offerings that change annually.In progressEnsure all Store Brand paper-based packaging is from recycled or certified sustainably sourced content by 20252025 As of December 31,2024,13%of paper packaging in store brand produc

74、ts have sustainable sourcing certification.Throughout 2024,we communicated with our suppliers about our expectations for all paper carton packaging.By the end of 2025,all paper cartons will be produced using either a recycled paper or from a certified sustainable source,such as Forest Stewardship Co

75、uncil(FSC),SFI(Sustainable Forestry Initiative),and Programme for the Endorsement of Forest Certification(PEFC).In progressBy 2023,define a list of packaging to be designated as problematic or unnecessary and take measures to eliminate them by 20302023 Weve identified these items and a full list can

76、 be found here.We are now working to build out the data system of all packaging components for all store brand items.This will allow us to sort,filter and search by specific packaging attributes.We have identified key features that we have defined to be problematic,such as single-use packaging conta

77、ining PVC and packaging that is not recyclable based on specific components.Through this system and with these definitions,we will be able to target individual items and components to implement more sustainable solutions to achieve our 2030 goals.Complete/in progressNext Section16Table of ContentsEm

78、ployment Type202420232022Full-time73%73%73%Part-time27%27%27%Employment+Gender202420232022Female70%70%70%Male29%30%30%Declined to self-identify1%1%1%Human Capital Data*Total employee count 313,823 as of 12/31/2024Employment+Age202420232022Under 3031%32%33%30-5044%43%42%Over 5025%25%25%Employment+Eth

79、nicity 202420232022White(not Hispanic or Latino)46%48%49%Black/African American(not Hispanic or Latino)18%18%18%Hispanic/Latino17%16%16%Asian(not Hispanic or Latino)12%12%12%Native Hawaiian or Other Pacific Islander(not Hispanic or Latino)1%1%1%American Indian/Alaskan Native(not Hispanic or Latino)1

80、%1%1%Two or more Races3%4%4%Declined to self-identify2%1%1%*The percentages in the tables throughout this section may not total 100 due to rounding.U.S.colleagues onlyNext Section17Table of ContentsBoard of Directors+Gender202420232022Female31%38%42%Male69%62%58%Executive Leadership Team and above+G

81、ender2024Female15%Male85%Declined to self-identify0%Human Capital DataGender by Employment LevelTotal Board Member Count:16 as of 12/31/2024Total Employee Count,Executive Leadership Team:13 as of 12/31/2024Vice President and Above+Gender202420232022Female43%40%39%Male57%60%60%Declined to self-identi

82、fy1%1%1%Total Employee Count,Vice President and Above:667 as of 12/31/2024Next Section18Table of ContentsHuman Capital DataGender by Employment LevelSelected Roles and GenderFemaleMaleDeclined to self-identifyCustomer Support Roles85%14%1%Nurses93%6%1%Nurse Practitioners and Physicians Assistants91%

83、8%1%Pharmacists62%37%1%Pharmacy Technicians79%20%1%Medical Directors61%39%0%Social Workers90%10%0%Care Concierge87%13%1%Field Leadership38%61%1%Front Store Colleagues63%37%1%Distribution Center Colleagues45%55%1%Hourly Wage Colleagues72%28%1%Next Section19Table of ContentsHuman Capital DataEthnicity

84、 by Employment LevelExecutive Leadership Team+Race/Ethnicity2024White(not Hispanic or Latino)62%Black/African American(not Hispanic or Latino)0%Hispanic/Latino0%Asian(not Hispanic or Latino)31%Native Hawaiian or Other Pacific Islander(not Hispanic or Latino)0%American Indian/Alaskan Native(not Hispa

85、nic or Latino)0%Two or more Races0%Declined to self-identify8%Total Employee Count,Executive Leadership Team:13 as of 12/31/2024Total Employee Count,Vice President and Above:667 as of 12/31/2024Vice President and Above+Race/Ethnicity202420232022White(not Hispanic or Latino)72%78%79%Black/African Ame

86、rican(not Hispanic or Latino)6%6%6%Hispanic/Latino4%4%3%Asian(not Hispanic or Latino)13%9%10%Native Hawaiian or Other Pacific Islander(not Hispanic or Latino)1%1%1%American Indian/Alaskan Native(not Hispanic or Latino)1%1%1%Two or more Races1%1%1%Declined to self-identify3%1%1%Next Section U.S.colle

87、agues only20Table of ContentsHuman Capital DataEthnicity by Employment Level Manager Level and Above+Race/Ethnicity202420232022White(not Hispanic or Latino)62%64%64%Black/African American(not Hispanic or Latino)11%10%10%Hispanic/Latino9%9%9%Asian(not Hispanic or Latino)14%14%13%Native Hawaiian or Ot

88、her Pacific Islander(not Hispanic or Latino)1%1%1%American Indian/Alaskan Native(not Hispanic or Latino)1%1%1%Two or more Races2%2%2%Declined to self-identify1%1%1%Total Employee Count,Manager Level and Above:34,540 as of 12/31/2024Next Section U.S.colleagues only21Table of ContentsRoleWhiteBlack/Af

89、ricanAmericanHispanic/LatinoAsianNativeHawaiianor OtherPacificIslander(not Hispanicor Latino)AmericanIndian/AlaskanNativeTwo orMore RacesDeclined to self-identifyCustomer Support Roles34%36%19%3%1%1%5%2%Nurses68%15%8%4%1%1%2%3%Nurse Practitioners and Physicians Assistants52%22%7%12%1%1%4%2%Pharmacis

90、ts52%13%4%27%1%1%2%2%Pharmacy Technicians42%18%19%14%1%1%4%2%Medical Directors54%16%6%19%0%1%1%4%Social Workers45%36%14%2%0%1%1%2%Care Concierge31%41%18%2%1%1%5%2%Field Leadership69%6%6%14%1%1%2%1%Front Store Colleagues44%17%24%8%1%1%4%2%Distribution Center Colleagues36%36%22%5%1%1%2%1%Hourly Wage C

91、olleagues43%20%19%12%1%1%4%2%Human Capital DataRace/Ethnicity by Selected RolesNext Section22Table of ContentsHuman Capital DataOccupational Data*OccupationalDataAllColleaguesRetailLocationColleaguesDistributionCenterColleaguesHealth CareDeliveryColleagues*OtherColleagues*Number of Work-Related Fata

92、lities43001Rate of Work-Related Fatalities*0.00170.0026000.001Number of Recordable Injuries3,7272,672546222287Rate of Recordable Injuries*1.5802.2907.4701.870Lost Time Injury(LTI)Frequency Rate*0.961.166.690.92Lost Time Injury(LTI)Severity Rate*32.4235.66323.5619.56List of the main types of work-rel

93、ated injuryStrains+ContusionsStrains+Contusions+PuncturesStrains+ContusionsPuncturesNumber of hours worked 471,908,413233,013,27814,613,10623,735,824.94200,546,204*This data does not include temporary labor.Temporary labor contracts are such that the companies that provide temporary labor are respon

94、sible for reporting their own injuries.*Rates are calculated based on 200,000 hours.*Categories added in 2024 through the creation of our health care delivery business segment.At CVS Health,we are committed to the health,safety,and well-being of our colleagues,customers,contractors,vendors,and other

95、 key stakeholders.Our occupational health and safety(OHS)program is applicable to our entire operations,including employees as well as clients,contractors,suppliers,and other visitors to our facilities.Learn more in our OHS Statement and Healthy BusinessNext Section23Table of ContentsNew Employee Hi

96、res110,133 new employee hires in 2024New Hires+Gender2024Female63%Male29%Declined to self-identify8%Human Capital DataEmployee Engagement DataWe believe engaged colleagues produce stronger business results and are more likely to build a career with the Company.Each year we conduct engagement surveys

97、 that provides colleagues with an opportunity to share their opinions and experiences with respect to their role,their team and the enterprise to help CVS Health Corporations Board of Directors(the“Board”)and our management identify areas where we can improve colleague experience.These surveys cover

98、 a broad range of topics including development and opportunities,recognition,performance,well-being,compliance and continuous improvement.In 2024,we conducted engagement surveys in both April and September.More than 150,000 colleagues participated in each survey and overall engagement stayed consist

99、ent across surveys.Levels of Employee EngagementCVS Health offers a number of resources and programs that attract,engage,develop,advance,and retain colleagues.Training and development provides colleagues the support they need to perform well in their current role while planning and preparing for fut

100、ure roles and career growth.We offer an online orientation program that pairs new hires with seasoned colleagues and the training continues throughout a colleagues career,through in-person,virtual,and self-paced learning at all levels.We also provide mentoring,tools and workshops for colleagues to m

101、anage their career development.We offer a variety of management and leadership programs that develop potential colleagues.In addition,we offer leadership development to all leaders across the organization to best support their growth and their leadership of our colleagues.Our broad training practice

102、s include updated,tech-enabled tools and keep our colleagues informed of new developments in our industry that are relevant to their roles.During the year ended December 31,2024,CVS Health colleagues invested approximately 16 million hours in learning and development courses.Our colleague developmen

103、t programming also promotes the importance of compliance across our business.CVS Health colleagues demonstrate this commitment through our annual Code of Conduct training,which nearly 100%of active colleagues completed in 2024.In 2024,we launched approximately 76 different training courses as part o

104、f our annual Enterprise Compliance Training Program.Average hours of training per employee per yearPaid parental leaveFull-time employees with 12 months of continuous service and welcome a new child into their home are eligible to take up to four weeks away from work at 100%of their pay to ensure th

105、e latest addition to their family gets off to a strong start in life.In 2024,9,641 colleagues requested an average of six weeks of paid parental leave,comprised of 73%women and 26%men.Next Section24Table of ContentsHuman Capital DataEmployee Engagement DataInvoluntary employee turnover in 2024 was 5

106、.7%;Voluntary employee turnover in 2024 was 27.3%Rate of colleagueturnover*:New Hires+Race/Ethnicity2024White(not Hispanic or Latino)33%Black/African American(not Hispanic or Latino)24%Hispanic/Latino19%Asian(not Hispanic or Latino)10%Native Hawaiian or Other Pacific Islander(not Hispanic or Latino)

107、1%American Indian/Alaskan Native(not Hispanic or Latino)1%Two or more Races4%Declined to self-identify10%New Hires+Age2024Up to 3054%30 to 5030%50+8%Declined to self-identify6%Next Section*FOR RATE OF COLLEAGUE TURNOVER:Full enterprise turnover rates are calculated by dividing the total number of in

108、voluntary or voluntary terminations among all colleagues by the total headcount of all colleagues.U.S.colleagues only.25Table of ContentsColleague Turnover+Gender*VoluntaryInvoluntaryFemale25%5%Male25%7%Colleague Turnover+Race/Ethnicity*VoluntaryInvoluntaryWhite(not Hispanic or Latino)21%3%Black/Afr

109、ican American(not Hispanic or Latino)33%10%Hispanic/Latino29%8%Asian(not Hispanic or Latino)22%3%Native Hawaiian or Pacific Islander(not Hispanic or Latino)27%6%American Indian/Alaskan Native(not Hispanic or Latino)28%8%Two or more Races34%8%Colleague turnover+Age*VoluntaryInvoluntaryUp to 3044%8%30

110、 to 5018%5%50+12%3%Number of positions filled by internal candidates 72,979Ratio of entry level wage to minimum wage2.100Percentage of employees earning minimum wage or higher100%Median annual compensation(2024)$42,640Human Capital DataEmployee Engagement DataNext Section U.S.colleagues only*FOR TUR

111、NOVER BY GENDER,AGE&RACE/ETHNICITY:Gender,age,and race/ethnicity turnover rates are calculated by dividing the total number of involuntary or voluntary terminations among each gender,age and race/ethnicity category by the total headcount of colleagues who identify in that respective category.Data is

112、 incomplete for colleagues who do not specify a race.26Table of ContentsHuman Capital DataEmployee Engagement DataLocation:StateAll ColleaguesAK$39.48AL$28.54AR$32.14AZ$36.21CA$32.35CO$43.60CT$42.26DC$32.26DE$30.99FL$29.33GA$31.32HI$25.37IA$32.83ID$34.43IL$38.18IN$28.16KS$34.27Average hourly wage by

113、 regionLocation:StateAll ColleaguesKY$31.35LA$29.52MA$33.00MD$31.10ME$36.82MI$29.11MN$37.68MO$30.70MS$28.92MT$34.34NC$30.57ND$32.01NE$35.96NH$33.57NJ$31.69NM$32.36NV$27.06Location:StateAll ColleaguesNY$30.34OH$31.56OK$31.10OR$37.78PA$31.26PR$33.09RI$43.53SC$29.09SD$44.10TN$27.63TX$31.57UT$35.00VA$31

114、.01VT$34.25WA$42.57WI$32.66WV$29.66WY$47.25Next Section U.S.colleagues only27Table of ContentsOur commitment tohuman rightsAt CVS Health,we are fundamentally committed to respecting and supporting internationally recognized human rights.Policy and governanceIn addition to respecting human rights by

115、preventing and mitigating adverse impacts of our business,we also promote human rights by taking actions that proactively contribute to the enjoyment of human rights.We do this by conducting proactive due diligence and complying with the United Nations Guiding Principles on Business and Human Rights

116、(UNGP).Our Human Rights Policy was approved by executive leadership,and oversight and responsibility for implementation of the policy rests with a cross-functional team,including members representing compliance,legal,procurement and human resources.Through engagement with leading nongovernmental,adv

117、ocacy and supply chain organizations and experts,we stay apprised of developments and emerging risks in the area of human rights and review and adjust our actions accordingly.We conduct human rights due diligence by identifying adverse impacts through human rights impact assessments,meaningful engag

118、ement with stakeholders across our value chain,and measuring and reporting on our findings and performance.We recognize that our employees are our greatest asset,and our business is most successful when they are treated with dignity and respect.We are committed to providing a positive,rewarding,and

119、safe work environment for every CVS Health colleague.Several resources are provided to colleagues to support our commitment,including information related to their legal rights as a CVS Health employee,policies in place to support a safe work environment,and expectations for conducting business ethic

120、ally and responsibly.Channels in place to inform our colleagues and leaders of their obligations,expectations and reporting vehicles include required and optional trainings,intranet resources and articles,direct communications,and signage in work locations.Equal opportunity and freedom from discrimi

121、nationOur continued success depends on the full participation of all qualified persons regardless of race,ethnicity,national origin,ancestry,color,religion,sex/gender,sexual orientation,gender identity or expression,physical or mental disability,medical condition(including pregnancy),age,veteran sta

122、tus,military status,marital status,genetic information,citizenship status,unemployment status,political affiliation,or on any other basis or characteristic prohibited by applicable federal,state or local law.We are committed to a work environment free of all types of discrimination.Learn moreFreedom

123、 of association and right to collective bargainingWe respect our employees right to either unionize or refrain from doing so.As of December 31,2024,5.3%of employees were covered by collective bargaining agreements.Providing training and resourcesWe offer multiple compliance courses that address huma

124、n rights topics,including discrimination and harassment,informed consent,and quality of care.This includes our annual Code of Conduct training,which nearly 100%of active colleagues completed in 2024.Through this annual training,colleagues receive and must acknowledge receipt of our human rights poli

125、cy.Our Commitment to colleaguesNext Section28Table of ContentsOur commitment tohuman rightsOur commitment to patients and customersAs part of our work to build a world of health around every consumer,we are committed to respecting and promoting our patients and customers human rights.This includes t

126、heir rights as patients of CVS Health care providers,protection of their privacy and data,the integrity of our products,and ourcommitment to responsible marketing practices.Through customer survey mechanisms,we work to gather the voice of the consumer in informing related policies and practices.Thro

127、ugh customer survey mechanisms,we work to gather the voice of the consumer in informing related policies and practices.Equal Opportunity Employer&Consumer Rights Occupational Health and Safety Minuteclinic Notice of Patient Rights Commitment to Responsible Marketing Practices Safety and Quality Test

128、ed to Be Trusted Privacy Policy Responsible Use of TechnologyOther policies that relate to the protection and promotion of human rights for patients and customers include:Other policies that relate to the protection and promotion of human rights for our colleagues include:Code of Conduct Equal Oppor

129、tunity Employer&Consumer Rights Employee Arbitration Program Occupational Health and SafetyLearn more about our impact:Colleague Safety Engaging and inclusive workplace UpdatesIn 2016,we began collaborating with experts at Business for Social Responsibility(BSR)to conduct regular human rights impact

130、 assessments and gap analyses informed by the UN Guiding Principles on Business and Human Rights.Following our assessment in 2016,we engaged with BSR to do a refresher assessment to identify and prioritize human rights risks through our operations,value chain,and business relationships and take appr

131、opriate actions to manage them.The most recent BSR assessment,concluded in the fall of 2021,accounted for evolving stakeholder expectations,emerging human rights issues and the growth of our enterprise.The assessment covered many issue areas including forced and child labor,human trafficking,freedom

132、 of association,right to collective bargaining,equal remunerations,discrimination,COVID-19,and product and patient safety.Our plan is to conduct regular assessments,which will allow us to focus on different groups within the enterprise and regularly monitor the entire business.Next Section29Table of

133、 ContentsOur commitment tohuman rightsWe require suppliers and their factories to provide fair and safe working conditions for all workers and to treat their employees with dignity and respect.To ensure factories are meeting local laws and international standards as it relates to human rights concer

134、ns,audits are conducted by our independent third-party audit firm partner,UL,through our Ethical Sourcing&CTPAT Compliance Program.The Ethical Sourcing&CTPAT Compliance Program focuses on human rights related areas such as child labor,forced labor,wages/benefits and health/safety.CVS Health maintain

135、s a strict Zero Tolerance policy when auditing factories and we take this commitment seriously.If a Zero Tolerance issue is found,the factory is immediately put on probation and orders are canceled.Alert Notification issues are serious issues that require immediate action.If an Alert Notification is

136、sue is found during an audit,factories must provide evidence that the issue has been addressed and undergo a verification process.Failure to successfully complete the verification process will result in the factory being placed on probation.A probationary period lasts one year,after which we conduct

137、 a new audit to determine if we will work together again.Social Compliance Audit SummaryZero Tolerance IssuesNumber of Audits Found to Have an IssueChild Labor1Abuse and Harassment0Bribery3Forced Prison Labor,Human Trafficking1Confirmed Falsified Audit Report and/or Business License0Intentional Non-

138、Disclosure of Finished Goods Subcontracting(Tier 1 and 5 Subcontractors)0Life Threatening Conditions*0*“Life Threatening Conditions”as a Zero Tolerance Issue is for situations in which CVS Health feels a factory is knowingly putting workers in harm by purposefully preventing or making it challenging

139、 for them to exit(ex:permanently locking/blocking exits and/or evacuation pathways).Where we are directly linked to human rights impacts through our business relationships,we seek ways to positively influence the human rights actions of our business partners,including our suppliers.Our commitment to

140、 supply chain communitiesNext Section30Table of ContentsAlert Notification IssuesNumber of Audits with Issues*Action TakenLife Threatening Finding(Locked/Blocked Exits,BlockedPathways)*36All factories provided evidence that the issue(s)had been corrected within the required timeframe.33 factories un

141、derwent the Verification process,which confirmed the issue(s)were not reoccurring.1 factory underwent the Verification process,which confirmed the issue(s)were not reoccurring,however new issue(s)were identified.Additional Verification took place,which confirmed the issue(s)were not reoccurring.1 fa

142、ctory is still in the Verification process.Discrimination4All factories provided evidence that the issue(s)had been corrected within the required timeframe.All factories underwent the Verification process,which confirmed the issue(s)were not reoccurring.Non-Disclosure of Finished GoodsSubcontracting

143、(Tier 1 and Tier 5 Subcontractors)11The suppliers provided information on their subcontractors within the required timeframe.All subcontractors were audited,and passed their audits.Missing Business License1The factory applied for and received a legal business license,at which point the issue was ver

144、ified.Passport Retention0N/ALife Threatening Finding AND Non-Disclosure of Finished Goods Subcontracting(Tier 1&Tier 5 Subcontractors)1The factory provided evidence that the issue(s)had been corrected within the required timeframe.The factory underwent the Verification process,which confirmed the is

145、sues were not reoccurring.The supplier provided information on their subcontractor within the required timeframe.The subcontractor was audited,and passed their audit.Life Threatening Finding(Locked/Blocked Exits,Blocked Pathways)AND Discrimination1The factory provided evidence that the issue(s)had b

146、een corrected within the required timeframe.The factory underwent the Verification process,which confirmed the issues were not reoccurring.Our commitment tohuman rights*To provide additional transparency and to more accurately disclose findings within our supply chain,the 2023 data reported in 2024

147、includes issues found in Tier 4 subcontractor factories,in addition to issues found in Primary,Tier 1,and Tier 5 factories which we have historically reported.“Life Threatening Finding”as an Alert Notification Issue captures situations in which there is no harmful intent on the part of the factory.N

148、ext Section31Table of ContentsOur commitment tohuman rightsA live virtual training for suppliers regarding our program requirements drew over 250 attendees in 2024.Over 1,000 suppliers and factories also participated in our e-Learning modules.In 2025,an updated e-learning module will target key audi

149、t finding trends.Other policies that relate to the protection and promotion of human rights in our supply chain include:Compliance/Ethics|CVS Health Suppliers Code of Conduct Occupational Health and Safety Safety and QualityTrainingNext Section32Table of ContentsOur commitment tohuman rightsReportin

150、g MechanismsAt CVS Health,we are fundamentally committed to respecting and supporting internationally recognized human rights.We promote various channels for reporting human rights concerns and work closely and collaboratively with stakeholders to understand and address concerns.Our process for inta

151、ke and review of concerns is detailed below.We promote various channels for reporting human rights concerns:Anyone wishing to report concerns or ask questions(including colleagues,vendors/suppliers,contractors,and consumers)may use the CVS Health Ethics Line to report concerns or ask questions by ca

152、lling confidentially and toll free at 1-877-CVS-2040.Colleagues can also escalate concerns or ask for advice by calling Colleague Relations.Our union colleagues submit grievances in accordance with their aligned collective bargaining agreement,working with a designated Labor Relations Grievance team

153、 and legal partners as appropriate.Additional support is provided to colleagues through training and resources.Consumers and the public can also contact CVS Health through our Customer Support line 1-800-SHOP-CVS or CVS Health Corporation,Customer Relations,One CVS Drive,Woonsocket,RI 02895.We work

154、closely and collaboratively with stakeholders to understand and address concerns.The CVS Health Ethics Line is available 24 hours per day,seven days per week,365 days per year for those reporting violations or concerns.Reports can be made via phone,email,or internet web form.All reports remain confi

155、dential to the extent reasonably possible.CVS Health utilizes an independent third party to receive incoming calls and web form reports to the Ethics Line,which can be submitted anonymously.The Ethics Line will triage the case to the appropriate investigative team and will follow up as needed on the

156、 status of the investigation.At the conclusion of the investigation,the investigator provides a summary of the investigation to the Ethics Line Team,which reviews the summary to confirm that all compliance concerns were evaluated,that the investigation was thorough,and that the outcome was reasonabl

157、e.If a compliance violation is found,appropriate corrective action is evaluated.The Ethics Line team provides updates as appropriate regarding status and case closure,though specific case closure details will not be provided.Ethics LineNext Section33Table of ContentsOur commitment tohuman rightsEthi

158、cs LineCustomer Support Line Customers can call the toll-free number on their ID or membership card.A natural language interactive voice response(IVR)will answer and ask the customer to state the reason for their call or complaint.Complaints are routed directly to a representative.The representative

159、 will gather pertinent information from the customer and document notes in their agent desktop.They assist the customer with any immediate needs,recap the conversation and next steps,and end the call.The customer is offered a survey either after the call or via email.Upon completion of the call,the

160、representative will route any complaints,via a task,to the complaints team.The complaints team promptly researches the issue and responds to the customer.Colleague RelationsColleague Relations provides objective guidance to both colleagues and leaders to address issues concerning work performance,wo

161、rkplace experience,or interaction among colleagues.When a case gets reported to Colleague Relations,it will be triaged to the appropriate team depending on the concern.The case is assessed,and a notice is provided to the complainant.A meeting is then set up with the colleague to review concerns.Coll

162、eagues and leaders partner with Colleague Relations Advisors on employee relations concerns,corrective action and performance.Colleague Relations Investigators investigate complaints involving potential violation of policy,law,or work rule.Following the conclusion of the review and/or investigation,

163、the case manager will contact the complainant to discuss the outcome of the case.Should a policy violation be found,possible outcomes could include coaching or training,a Performance Improvement Plan,and/or progressive discipline up to,and including,termination.Next Section34Table of ContentsNNYearE

164、lectricity(Million Mwh)Natural Gas(Million Therms)Propane&Oil(Therms)Fuel Consumption(Million Gallons)*20222.222.5551,8225.920232.119.8408,3598.120241.923.7428,9678.8Environmental Data*CVS Health is committed to reducing the impacts of our operations.Total Energy Usage by Type(2022-2024)Energy Usage

165、 and Greenhouse Gas DataYearC02e*(MT)Reduction against Baseline20191,193,890N/A20221,036,511-13%2023983,724-18%2024856,958-28%2030 Target632,762-47%Progress Towards 1.5-degree SBT 2022-2024,2019 BaselineYearEmissions Intensity(mtC02e/$mil Revenue)20242.30Intensity MetricsNext SectionMore information

166、 on our programs and initiatives is detailed in our Healthy 2030 report Healthy Planet section.We have set ambitious goals and report on our progress annually.Learn more in Tracking Our Progress.Additional information on our climate-related progress,is available in our Climate-related risks and oppo

167、rtunity disclosure.*The percentages in the tables throughout this section may not total 100 due to rounding.*Scope 1 and 2 market-based method35Table of ContentsEnvironmental DataGHG Emissions(Metric Tonnes of C02e)2022-2024,2019 baselineTonnes ofc02e%of total Scope 1 and 2(market-based)emissionsTon

168、nes ofc02e%of total Scope 1 and 2(market-based)emissionsTonnes ofc02e%of total Scope 1 and 2(market-based)emissionsScope 1 Total261,52231%269,22527%250,02224%Natural Gas110,73313%105,24511%120,00512%Other Fuels2,7211%2,7321%3,0731%Corporate Fleets31,3564%42,3514%19,1902%Private Delivery Fleet39,9875

169、%33,5673%31,3853%Refrigerants65,5388%85,3309%71,0987%Air Fleet11,1871%7,5011%5,2711%Scope 1 Breakdown202420232022Tonnes ofc02e%of total Scope 1 and 2(market-based)emissions157,19913%77,6647%3,1041%8,8611%30,2503%30,6813%6,6391%2019Tonnes ofc02e%of total Scope 1 and 2(market-based)emissionsTonnes ofc

170、02e%of total Scope 1 and 2(market-based)emissionsTonnes ofc02e%of total Scope 1 and 2(market-based)emissionsScope 2 Total (Market-based)595,70069%714,49973%786,48976%Scope 2 Total (Location-based)653,702N/A718,743N/A795,681N/AScope 1 and 2 Total(Market-based)857,222100%983,724100%1,036,511100%Scope

171、2*Breakdown202420232022Tonnes ofc02e%of total Scope 1 and 2(market-based)emissions1,036,69087%1,024,682N/A1,193,890100%2019*Scope 2 emissions are based on purchased electricity,steam,and chilled water.Next SectionGHG Emissions by Scope 2022-2024A breakdown of Scope 1,2 and 3 data are included below.

172、The baseline year for data provided is 2019;the standards used arein accordance with the Greenhouse Gas Protocol published by the World Resources Institute and the World Business Council for Sustainable Development,as well as the Climate Registrys General Reporting Protocol;and the consolidation app

173、roach is based on operational control.36Table of ContentsEnvironmental DataTonnes ofc02e%of total Scope 3 emissionsTonnes ofc02e%of total Scope 3 emissionsTonnes ofc02e%of total Scope 3 emissionssScope 3 Total11,387,115100%10,449,781100%14,286,071100%1.Purchased goods+Services9,853,46287%9,113,14287

174、%12,959,46591%2.Capital Goods268,7552%179,5042%171,5111%3.Fuel+Energy related activities266,0273%287,8663%306,9572%4.Upstream Transportation292,4463%230,1162%247,8072%5.Waste127,4901%129,9251%103,1981%6.Business Travel57,0981%51,7580.5%39,7370.0%Business Air Travel16,5631%17,3690.2%11,0110.3%Rental

175、Cars5,4951%6,9720.1%5,9090.3%Personal Car29,8441%24,6260.2%19,3030.3%Hotel Stays4,8501%2,7090.0%2,2560.0%Rail Travel3461%820.0%660.0%7.Employee Commuting493,8394%436,2394%437,7073%8.Upstream Leased Assets27,9971%20,0900.2%19,7060.0%9.Downstream Transport&Distribution#N/A%#N/A0.0%#N/A0.0%10.Processin

176、g of Sold Products#N/A0.0%#N/A0.0%#N/A0.0%11.Use of Sold Products#N/A0.0%#N/A0.0%#N/A0.0%12.End-of-life Sold Products#N/A0.0%#N/A0.0%#N/A0.0%13.Downstream Leased Assets#N/A0.0%#N/A0.0%#N/A0.0%14.Franchises#N/A0.0%#N/A0.0%#N/A0.0%15.Investments#N/A0.0%#N/A0.0%#N/A0.0%Scope 3 Breakdown2024202320222019

177、Tonnes ofc02e%of total Scope 3 emissions24,608,123100%23,184,94494%1,011,7304%51,6570.2%116,3740.5%106,7960.4%77,964%10,199%18,632%20,4000.1%116,2220.5%Next Section37Table of ContentsEnvironmental DataWaste DataWaste Disposal MethodsWaste inTonnes%*Waste inTonnes%*Waste inTonnes%*Total Waste Generat

178、ed4,751100%5,561100%9,606100%Total Hazardous*1,77937%2,14139%5,27755%Total Non-Hazardous*2,35350%2,79850%3,44736%Total Regulated Medical Waste(RMW)61913%62111%8819%Waste Reused10%0.50%0.20%Total Hazardous*02%00%00%Total Non-Hazardous*198%0.5100%0.2100%Total Regulated Medical Waste(RMW)00%00%00%Waste

179、 Recycled2,00542%2,37643%5,63145%Total Hazardous*89945%1,27153%3,78767%Total Non-Hazardous*51426%51222%96417%Total Regulated Medical Waste(RMW)59330%59425%88016%Waste Incinerated with Energy Recovery1,61534%1,97936%2,09435%Total Hazardous*1298%00%00%Total Non-Hazardous*1,48392%1,979100%2,094100%Tota

180、l Regulated Medical Waste(RMW)30%00%00%Waste Incinerated without Energy Recovery1,01821%1,18221%1,79619%Total Hazardous*75174%87074%1,48583%Total Non-Hazardous*25925%28524%31117%Total Regulated Medical Waste(RMW)81%272%0.30%Waste to Landfill1122%230.4%840.9%Total Hazardous*10%14%56%Total Non-Hazardo

181、us*9686%2296%7994%Total Regulated Medical Waste(RMW)1514%00%00%202420232022Regulated Waste Disposal Methods 2022-2024Next Section38Table of Contents*Percentages that do not total 100 percent are due to rounding.*The waste categories included are hazardous waste and hazardous pharmaceutical waste.*Th

182、e waste categories included are non-hazardous regulated waste,non-hazardous pharmaceutical waste,and organics.Environmental DataWaste DataWater DataWater Use Intensity Measurement(2022-2024)YearTotal Water Usage (ML)SF of Retail Space (Millions)Normalized Water Usage (Per SF of Retail Space in ML)20

183、226,30378.90.00008020235,01776.20.00006620246,59074.10.000089Recycling Figures 2023Other recycling figures:6.1 metric tons of mixed paper 1.3 metric tons of plastic bottles&cans 1433.9 metric tons of white paper4.5 metric tons of plastic bags were diverted from landfills to our plastic bag recycling

184、 program197,981metric tons were recycled through all programs at retail stores,corporate offices and distribution centers(including Coram,Caremark and Omnicare)50%Our overall diversion rate for 2024,meaning half of all our waste is diverted from landfillNext Section39Table of ContentsAbout this repo

185、rtCVS Healths annual Healthy 2030 Impact Report provides an overview of our Companys environmental and social commitments,as well as progress against certain priorities,goals and targets.Boundary and scopeConsistent with previous reports,the boundaries for this report extend to all United States com

186、pany-owned and/or operated facilities,administrative offices and retail pharmacies for the corporate enterprise.Company operations outside the U.S.are limited and included in this report and accompanying Appendix,unless otherwise noted,including Cordavis.Data contained in this report covers activiti

187、es that occurred in fiscal 2024(January 1 December 31,2024)unless otherwise noted.Content and materialityIn 2023,we completed a prioritization assessment in accordance with the Global Reporting Initiative(GRI)Standards guidance for defining priority topics and in collaboration with BSR(Business for

188、Social Responsibility).The topics inform the content of our reporting and Healthy 2030 strategy.For additional details,please see Prioritization Assessment.We use the terms“prioritization assessment and priority topics”in our Healthy 2030 impact reporting to reference which topics are most important

189、 to our stakeholders and our business.Due to the varied interests of our stakeholder groups,not all of the identified topics are material to the Company as such term is defined under applicable securities laws.The inclusion of topics in this assessment and the inclusion of information in this report

190、 generally should not be construed as a characterization regarding its materiality or significance for any other purpose,including for purposes of applicable securities laws.Next Section40Table of ContentsYour feedbackYour feedback is important to us as we continue to look for ways to improve our re

191、porting and provide you with the information you need.Please submit your feedback to:CSRCVSHCVS Health CorporationAttn:CSO&SVP,Corporate Social Responsibility and PhilanthropyOne CVS Drive,MC 1200,Woonsocket,RI 02895401-765-1500(TTY:711)About this reportPreparation of this reportThis report contains

192、 certain forward-looking statements that are subject to risks and uncertainties.Actual results may differ materially from those contemplated by the forward-looking information for a number of reasons as described in our Securities and Exchange Commission(SEC)filings,including those set forth in the“

193、Risk Factors”section and under the section entitled“Cautionary Statement Concerning Forward-Looking Statements”in our most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q.We refer readers of this Report to all our SEC filings,including our Annual Report to Stockholders,ou

194、r Form 10-K,Forms 10-Q and any Forms 8-K,which provide important information about our business,operations and financial performance.Before making any investment or other decision relating to CVS Health,all such public filings should be considered in detail.References in this document to CVS Health

195、products,programs or services do not imply that CVS Health intends to provide all products,programs or services across all of its businesses.Statements regarding the future direction and intent of CVS Health are subject to change or withdrawal without notice and represent goals and objectives only.D

196、isclosure and assuranceCVS Health management is responsible for the preparation and integrity of the information in this report.The enterprise metrics and goals in this report are established through a rigorous review process involving internal subject matter experts,and we believe this report accur

197、ately and fairly represents our activities,programs and results for the fiscal year ending December 31,2024.The report was submitted to the board of directors and was reviewed and approved by members of CVS Health senior management,including our steering committee,as well as the disclosure committee

198、,each of which is comprised of management from principal functional areas within the Company.CVS Health carbon footprint and water data from 2016-2024 has been externally assured.The Healthy 2030 Impact Report Appendix has also been reviewed and assured to the AA1000 standard.Verification statements

199、 are available on our report archives website.The Company may consider having additional content and data in its future impact reports externally assured.This report was produced based on the GRI Standards.More information is available at GlobalReporting.org.Full indices for the GRI Standards and th

200、e Sustainability Accounting Standards Board(SASB),as well as our contributions to the United Nations Sustainable Development Goals(UNSDGs)are available in the appendix to this report.Our Climate-Related Disclosure,prepared to reflect the recommendations of the Task Force on Climate Related Financial

201、 Disclosures(TCFD)and the International Sustainability Standards Boards International Financial Reporting Standards(ISSB-IFRS),is available in the appendix.Next Section41Table of ContentsGlobal Reporting Initiative (GRI Index)The 2024 CVS Health Impact Report has been developed in accordance withthe

202、 GRI Standards(2021)for the period from January 1,2024 to December 31,2024.CVS Health also supports the Culture of Health for Business Framework,which was developed in 2019 by a group of leading companies,nonprofits andacademia with support from the Robert Wood Johnson Foundation.Disclosures reflect

203、ed within that Framework are included within our GRI Index disclosures.GRI Disclosure No.GRI Disclosure Title2024 CVS Health Response2-1Organization detailsCorporate Profile,p.3,2024 Impact Report AppendixCVS Health Corporation is a publicly traded corporation on the New York Stock Exchange.Ticker S

204、ymbol:CVSCorporate Headquarters is located at:CVS Health1 CVS DriveWoonsocket,RI 028952-2Entities included in the organizations sustainability reportingAbout this Report,p.40-41,2024 Impact Report Appendix2025 Proxy Statement2-3Reporting period,frequencyand contact pointAbout this Report,p.40-41,202

205、4 Impact Report AppendixReporting period covers calendar year 2024,January 1-December 31,2024.Both sustainability and financial reporting cycles at CVS Health run on a calendar year.Report publication,April 4,2025CSRCVSHCVS Health CorporationAttn:SVP and CSO,Corporate Social Responsibility&Philanthr

206、opy1 CVS Drive,Woonsocket,RI 02895401-765-15002-4Restatements of informationNone2-5External AssuranceCVS Health carbon footprint and water data from 2016-2023 have been externally assured.Data from 2024 will be reviewed and assured in the coming weeks and updated within this report upon completion.V

207、erification statements are available on our report archives website.The Company may consider having additional content and data in its future Impact Reports externally assured.Organizational&ReportingNext Section42Table of Contents2-6Activities,value chain and other business relationshipsCorporate P

208、rofile,p.3,2024 Impact Report AppendixCreating ValueAbout this Report,p.40-41,2024 Impact Report Appendix2-7EmployeesAll work is performed by our companys employees,with a large majority of them performing retail-related duties and are located primarily in the U.S.Human Capital Data,p.17,2024 Impact

209、 Report Appendix2-8Workers who are not employeesCVS Health employees are both full and part-time employees as well as third-party contractors.Human Capital Data,p.17,2024 Impact Report AppendixAbout this Report,p.40-41,2024 Impact Report AppendixRequirements 2-8-b and 2-8-c:Confidentiality constrain

210、ts:We does not publicly disclose this data.CVS Health contractors are not included within the boundaries of our reporting as they are considered employees of their respective organizations we do business with.Global Reporting Initiative (GRI Index)GRI Disclosure No.GRI Disclosure Title2024 CVS Healt

211、h Response2-9Governance structure and compositionHealthy 2030 Strategy&Governance,p.4,2024 Impact Report AppendixCommittees of the Board,2025 Proxy Statement2-10Nomination and the selection of the highestgovernance bodyCVS Health Corporate Governance Guidelines2-11Chair of the highest governance bod

212、yBoard Structure and Processes,2025 Proxy StatementRoger Farah serves as Executive Chair of our Board of Directors and Michael F.Mahoney serves as Lead Independent Chair of our Board of Directors2-12Role of the highest governance body inoverseeing the management of impactsHealthy 2030 Impact Strateg

213、y&Governance,p.4,2024 Impact Report AppendixStakeholder Engagement,p.9-11,2024 Impact Report Appendix2025 Proxy Statement 2-13Delegation of responsibility for managing impactsHealthy 2030 Impact Strategy&Governance,p.4,2024 Impact Report AppendixGovernanceOrganizational&Reporting Cont.Next Section43

214、Table of Contents2-14Role of the highest governance body insustainability reportingHealthy 2030 Impact Strategy&Governance,p.4,2024 Impact Report Appendix2-15Conflicts of interestRelated Person Transaction Policy,2025 Proxy Statement CVS Health-Investors-Corporate Governance-GuidelinesCVS Health Cod

215、e of Conduct2-16Communication of critical concernsHealthy 2030 Impact Strategy&Governance,p.4,2024 Impact Report AppendixStakeholder Engagement,p.9-11,2024 Impact Report AppendixOur commitment to human rights,p.28,2024 Impact Report AppendixInformation unavailable/incomplete.There are many ways in w

216、hich critical concerns of stakeholders are brought to our Board of Directors.Our President and CEO and executive leadership team bring these issues to our Board on an on-going basis.2-17Collective knowledge of the highest governance bodyCommittees of the Board,2025 Proxy StatementCVS Health Corporat

217、e Governance Guidelines2-18Evaluation of the performance of the highestgovernance bodyCVS Health Corporate Governance Guidelines2025 Proxy Statement2-19Remuneration policiesCompensation Discussion and Analysis,2025 Proxy StatementCVS Health Corporate Governance GuidelinesHealthy 2030 Impact Strategy

218、&Governance,p.4,2024 Impact Report Appendix2-20Process to determine remunerationCompensation Discussion and Analysis,2025 Proxy StatementCVS Health Corporate Governance Guidelines2-21Annual total compensationratioCompensation Discussion and Analysis,2025 Proxy StatementGlobal Reporting Initiative (G

219、RI Index)Governance Cont.Next Section44Table of ContentsGRI Disclosure No.GRI Disclosure Title2024 CVS Health Response2-23Policy commitmentsAll CVS Health colleagues,members of its Board of Directors,and some suppliers,are required to acknowledge receipt of the Code of Conduct and Human Rights Polic

220、y annually.Additionally,all colleagues must complete an annual Code of Conduct andCompliance training.In 2024,nearly 100%of active colleagues completed this training.CVS Health Code of Conduct CVS Health Human Rights Policy2-24Embedding policy commitmentsAll CVS Health colleagues,members of its Boar

221、d of Directors,and suppliers,are required to acknowledge receipt of the Code of Conduct and Human Rights Policy annually.Additionally,all colleagues must complete an annual Code of Conduct andCompliance training.In 2024,nearly 100%of active colleagues completed this training.CVS Health Code of Condu

222、ct CVS Health Human Rights Policy2-25Process to remediate negative impactsCVS Health Code of Conduct CVS Health Human Rights PolicyCVS Health Ethics Line 1-877-CVS-2040Our Commitment to human rights,p.33,2024 Impact Report Appendix2-26Mechanisms for seeking advise and raising concernsCVS Health Code

223、 of ConductCVS Health Ethics Line 1-877-CVS-2040Our commitment to human rights,p.33-34,2024 Impact Report Appendix2-27Compliance with laws and regulationsCVS Health Form 10-KAny significant instances of noncompliance with laws and regulations and material fines in the current and prior reporting per

224、iods are set forth in our annual reports on Forms 10-K filed with the SEC,which include our audited financial statements.2-28Membership AssociationsStakeholder Engagement,p.9-11,2024 Impact Report AppendixStakeholder EngagementEthics and IntegrityGlobal Reporting Initiative (GRI Index)Next SectionGR

225、I Disclosure No.GRI Disclosure Title2024 CVS Health Response2-22Statement on sustainable development strategyLetter from CEO,Executive Chair and Lead Independent Director of the BoardLetter from Chief Sustainability OfficerStrategy45Table of ContentsGRI Disclosure No.GRI Disclosure Title2024 CVS Hea

226、lth Response2-29Approach to stakeholder engagementStakeholder Engagement,p.9-11,2024 Impact Report AppendixStakeholder Engagement2-30Collective bargaining agreementsAs of December 31,2024,5.3%of employees were covered by collective bargaining agreements.In the fall of 2021,CVS Health finalized the n

227、egotiation of a successor collective bargaining agreement with eight union locals representing our employees in many of our California retail locations.Through good faith negotiations we were able toaddress the concerns of our employees related to health care costs,store safety and wages.The final a

228、greement was endorsed by all of the unions and overwhelmingly ratified by our employees.Wage increases have already been implemented in theselocations.Stakeholder EngagementGlobal Reporting Initiative (GRI Index)GRI Disclosure No.GRI Disclosure Title2024 CVS Health Response3-1Process to determine ma

229、terial topicsAbout this Report,p.40-41,2024 Impact Report AppendixPrioritization Assessment,p.8,2024 Impact Report AppendixStakeholder Engagement,p.9-11,2024 Impact Report Appendix3-2List of material topicsPrioritization Assessment,p.8,2024 Impact Report Appendix3-3Management of material topicsHealt

230、hy 2030 Impact Strategy&Governance,p.4,2024 Impact Report AppendixPrioritization Assessment,p.8,2024 Impact Report AppendixStakeholder Engagement,p.9-11,2024 Impact Report AppendixMaterial TopicsNext Section46Table of ContentsGRI Disclosure No.GRI Disclosure Title2024 CVS Health Response3-3Managemen

231、t of material topicsHealthy 2030 Impact Strategy&Governance,p.4,2024 Impact Report AppendixPrioritization Assessment,p.8,2024 Impact Report AppendixStakeholder Engagement,p.9-11,2024 Impact Report Appendix201-1Direct economic value generated and distributedCorporate Profile,p.3,2024 Impact Report Ap

232、pendixCVS Health does not currently capture EVG&D data by country/region/market levels.201-2Financial implications and other risks and opportunities due to climate changeClimate Disclosure,p.73,2024 Impact Report Appendix201-3Defined benefit plan obligations and otherretirement plansConfidentiality

233、constraints:CVS Healthconsiders these data points to be confidential.201-4Financial assistance received from governmentConfidentiality constraints:CVS Healthconsiders these data points to be confidential.201:Economic PerformanceGlobal Reporting Initiative (GRI Index)GRI Disclosure No.GRI Disclosure

234、Title2024 CVS Health Response3-3Management of material topicsAbout this Report,p.40-41,2024 Impact Report Appendix;Prioritization Assessment,p.8,2024 Impact Report AppendixStakeholder Engagement,p.9-11,2024 Impact Report Appendix202-1Ratios of standard entry level wage by gendercompared to local min

235、imum wageHuman Capital Data,p.27,2024 Impact Report AppendixAs a company with a national footprint,we have broken this data out by state.202-2Proportion of senior management hired fromthe local community100%of senior leaders at Vice President level and above live in the United States.Regional locati

236、on data for Oak Street Health,Signify Health,and Cordavis is unavailable202:Market PresenceNext Section47Table of ContentsGRI Disclosure No.GRI Disclosure Title2024 CVS Health Response3-3Management of material topicsHealthy 2030 Impact Strategy&Governance,p.4,2024 Impact Report AppendixPrioritizatio

237、n Assessment,p.8,2024 Impact Report AppendixStakeholder Engagement,p.9-11,2024 Impact Report Appendix203-1Infrastructure investments and services supportedIn 2024,we provided more than$239M in Philanthropic giving.Healthy CommunityCorporate Profile,p.3,2024 Impact Report AppendixIn 2024,CVS Health i

238、nvested$266 million in affordable housing and$1.9 billion since inception.203-2Significant indirect economic impactsopportunities due to climate changeHealthy Business203:Indirect Economic ImpactsGlobal Reporting Initiative (GRI Index)GRI Disclosure No.GRI Disclosure Title2024 CVS Health Response3-3

239、Management of material topicsHealthy 2030 Impact Strategy&Governance,p.4,2024 Impact Report AppendixPrioritization Assessment,p.8,2024 Impact Report AppendixStakeholder Engagement,p.9-11,2024 Impact Report Appendix204-1Proportion of spendingon local suppliersConfidentiality constraints:CVS Health co

240、nsiders these data points to be confidential.204:Procurement PracticesGRI Disclosure No.GRI Disclosure Title2024 CVS Health Response3-3Management of material topicsHealthy 2030 Impact Strategy&Governance,p.4,2024 Impact Report AppendixPrioritization Assessment,p.8,2024 Impact Report AppendixStakehol

241、der Engagement,p.9-11,2024 Impact Report Appendix205-1Operations assessed for risks related to corruptionSocial Compliance Audit Summary,p.30-31,2024 Impact Report Appendix205:Anti-CorruptionNext Section48Table of Contents205-2Communication and training about anti-corruption policies and procedures1

242、00%of CVS Health colleagues are required to acknowledge receipt of the Code of Conduct and complete an annual Code of Conduct and Compliance training.Members of our Board of Directors,when doing work for CVS Health,as well as some supplier partners,are also governed by the Code of Conduct.CVS Health

243、 Code of Conduct205-3Confirmed incidents of corruption and actionstakenSocial Compliance Audit Summary,p.30-31,2024 Impact Report AppendixGlobal Reporting Initiative (GRI Index)GRI Disclosure No.GRI Disclosure Title2024 CVS Health Response3-3Management of material topicsHealthy 2030 Impact Strategy&

244、Governance,p.4,2024 Impact Report AppendixPrioritization Assessment,p.8,2024 Impact Report AppendixStakeholder Engagement,p.9-11,2024 Impact Report Appendix206-1Legal actions for anti-competitive behavior,anti-trust,and monopoly practicesConfidentiality constraints:CVS Health considers these data po

245、ints confidential.206:Anti-Competitive BehaviorGRI Disclosure No.GRI Disclosure Title2024 CVS Health Response3-3Management of material topicsHealthy 2030 Impact Strategy&Governance,p.4,2024 Impact Report AppendixPrioritization Assessment,p.8,2024 Impact Report AppendixStakeholder Engagement,p.9-11,2

246、024 Impact Report Appendix301-1Materials used by weight or volumeIn 2024,we used 31,420.71 metric tons of plastic;16%contained PCR.Tracking Our Progress,p.15-16,2024 Impact Report AppendixHealthy Planet Resource:Plastic Progress Report301:Materials302-2Recycled input materials used303-3Reclaimed pro

247、ducts and their packaging materialsNext Section49Table of ContentsGRI Disclosure No.GRI Disclosure Title2024 CVS Health Response3-3Management of material topicsHealthy 2030 Impact Strategy&Governance,p.4,2024 Impact Report AppendixPrioritization Assessment,p.8,2024 Impact Report AppendixStakeholder

248、Engagement,p.9-11,2024 Impact Report Appendix302-1Energy consumption within the organizationTotal Energy Usage by Type,GHG Emissions,EnvironmentalData,p.35,2024 Impact Report Appendix;Energy Consumption(Global),p.60,2024 Impact Report Appendix302-2Energy consumption outside of the organizationTotal

249、Energy Usage by Type,GHG Emissions,EnvironmentalData,p.35,2024 Impact Report Appendix;Energy Consumption(Global),p.60,2024 Impact Report Appendix302-3Energy intensityTotal Energy Usage by Type,GHG Emissions,EnvironmentalData,p.35,2024 Impact Report Appendix;Energy Consumption(Global),p.60,2024 Impac

250、t Report Appendix302-4Reduction of energy consumptionTotal Energy Usage by Type,GHG Emissions,EnvironmentalData,p.35,2024 Impact Report Appendix;Energy Consumption(Global),p.60,2024 Impact Report Appendix302-5Reductions in energy requirements of productsand servicesTotal Energy Usage by Type,GHG Emi

251、ssions,EnvironmentalData,p.35,2024 Impact Report Appendix;Energy Consumption(Global),p.60,2024 Impact Report Appendix302:EnergyGlobal Reporting Initiative (GRI Index)Next Section50Table of ContentsGRI Disclosure No.GRI Disclosure Title2024 CVS Health Response3-3Management of material topicsHealthy 2

252、030 Impact Strategy&Governance,p.4,2024 Impact Report AppendixPrioritization Assessment,p.8,2024 Impact Report AppendixStakeholder Engagement,p.9-11,2024 Impact Report Appendix303-1Interactions with water as a shared resourceWater Use Intensity Measurement,Environmental Data,p.39,2024 Impact Report

253、AppendixWater Management,p.61,2024 Impact Report Appendix303-2Management of water discharge-related impactsWater Use Intensity Measurement,Environmental Data,p.39,2024 Impact Report AppendixWater Management,p.61,2024 Impact Report Appendix303-3Water withdrawalWater Use Intensity Measurement,Environm

254、ental Data,p.39,2024 Impact Report AppendixWater Management,p.61,2024 Impact Report Appendix303-4Water dischargeNot applicable:Nearly all of our water is discharged to local municipal treatment plants or to groundwater from irrigation;a small subset of sites,about 105,discharge into local septic sys

255、tems.The rest discharges into municipal sewers.303-5Water consumptionNot applicable:We do not store water.303:Water&EffluentsGlobal Reporting Initiative (GRI Index)GRI Disclosure No.GRI Disclosure Title2024 CVS Health Response3-3Management of material topicsHealthy 2030 Impact Strategy&Governance,p.

256、4,2024 Impact Report AppendixPrioritization Assessment,p.8,2024 Impact Report AppendixStakeholder Engagement,p.9-11,2024 Impact Report Appendix305-1Direct(Scope 1)GHG emissionsGHG Emissions,Environmental Data,p.36,2024 Impact Report Appendix CO2,CH4,N20,and HFCs are included in our GHG calculations3

257、05-2Energy indirect(Scope 2)GHG emissionsGHG Emissions,Environmental Data,p.36,2024 Impact Report Appendix CO2,CH4,N20,and HFCs are included in our GHG calculations305:EmissionsNext Section51Table of Contents305-3Other indirect(Scope 3)GHG emissionsGHG Emissions,Environmental Data,p.37,2024 Impact R

258、eport Appendix305-4GHG emissions intensityGHG Emissions,Environmental Data,p.35,2024 Impact Report Appendix305-5Reduction of GHGemissionsGHG Emissions,Environmental Data,p.35,2024 Impact Report Appendix305-6Emissions of ozoneozone-depleting substances(ODS)Not Applicable:CVS Health determined not mat

259、erial.305-7Nitrogen oxides(NOx),sulfur oxides(SOx),and other significant air emissionsNot Applicable:CVS Health determined not material.Global Reporting Initiative (GRI Index)GRI Disclosure No.GRI Disclosure Title2024 CVS Health Response3-3Management of material topicsHealthy 2030 Impact Strategy&Go

260、vernance,p.4,2024 Impact Report Appendix;Prioritization Assessment,p.8,2024 Impact Report AppendixStakeholder Engagement,p.9-11,2024 Impact Report Appendix306-1Waste generation and significant waste-related impactsRegulated Waste Disposal Methods,p.38,2024 Impact Report AppendixEmbedding Sustainabil

261、ity at Retail,Meeting Ambitious Sustainable Packaging Goals,p.37,2022 Impact ReportReducing Waste and Expanding Recycling,p.118-119,2020 CSR ReportDecreasing Waste,Increasing Recycling,p.100-104,2019 CSR ReportMinimizing Waste and Increasing Recycling,p.69-71,2018 CSR Report306-2Management of waste-

262、relatedimpactsRegulated Waste Disposal Methods,p.38,2024 Impact Report AppendixRecycling Impact,p.39,2024 Impact Report Appendix306-3Waste generationRegulated Waste Disposal Methods,p.38,2024 Impact Report AppendixRecycling Impact,p.39,2024 Impact Report Appendix306-4Waste diverted from disposalRegu

263、lated Waste Disposal Methods,p.38,2024 Impact Report Appendix Recycling Impact,p.39,2024 Impact Report Appendix306:Waste305:Emissions Cont.Next Section52Table of Contents306-5Waste directed to disposalRegulated Waste Disposal Methods,p.38,2024 Impact Report Appendix Recycling Impact,p.39,2024 Impact

264、 Report AppendixGlobal Reporting Initiative (GRI Index)GRI Disclosure No.GRI Disclosure Title2024 CVS Health Response3-3Management of material topicsHealthy 2030 Impact Strategy&Governance,p.4,2024 Impact Report Appendix;Prioritization Assessment,p.8,2024 Impact Report AppendixStakeholder Engagement

265、,p.9-11,2024 Impact Report Appendix308-1New suppliers that were screened usingenvironmental criteriaCVS Health includes environmental guidance in supplier requests for proposals.We also evaluated suppliers of our Store Brand products for environmental criteria through our social compliance program.C

266、VS Health and suppliers are engaged in legal agreements and therefore subject to confidentiality.308-2Negative environmental impacts in the supplychain and actions takenCVS Health and suppliers are engaged in legal agreements and therefore subject to confidentiality.308:Supplier Environmental Assess

267、mentGRI Disclosure No.GRI Disclosure Title2024 CVS Health Response3-3Management of material topicsHealthy 2030 Impact Strategy&Governance,p.4,2024 Impact Report Appendix;Prioritization Assessment,p.8,2024 Impact Report AppendixStakeholder Engagement,p.9-11,2024 Impact Report Appendix401-1New employe

268、e hires and employee turnoverEmployee Recruitment,Development&Retention,p.24-25,2024 Impact Report AppendixJob security and pay practices data,p.24-27,2024 Impact Report Appendix401-2Benefits provided to fullfull-time employees thatare not provided to temporary or part-timeemployeesHealthy BusinessC

269、VS Health Benefits401-3Parental leaveOccupational Health and Safety StatementCVS Health Code of ConductHuman Capital Data,p.24,2024 Impact Report Appendix 401:Employment306:Waste Cont.Next Section53Table of ContentsGRI Disclosure No.GRI Disclosure Title2024 CVS Health Response3-3Management of materi

270、al topicsHealthy 2030 Impact Strategy&Governance,p.4,2024 Impact Report AppendixPrioritization Assessment,p.8,2024 Impact Report AppendixStakeholder Engagement,p.9-11,2024 Impact Report Appendix403-1Occupational health and safety managementsystemOccupational Health and Safety StatementCVS Health Cod

271、e of ConductHuman Capital Data,p.23 2024 Impact Report Appendix 403-2Hazard identification,risk assessment,andincident investigationOccupational Health and Safety StatementCVS Health Code of ConductHuman Capital Data,p.23 2024 Impact Report Appendix 403-3Occupational health servicesOccupational Heal

272、th and Safety StatementCVS Health Code of ConductHuman Capital Data,p.23 2024 Impact Report Appendix 403-4Worker participation,consultation,andcommunication on occupational health andsafetyOccupational Health and Safety StatementCVS Health Code of ConductHuman Capital Data,p.23 2024 Impact Report Ap

273、pendix 403-5Worker training on occupational health andsafetyOccupational Health and Safety StatementCVS Health Code of ConductHuman Capital Data,p.23 2024 Impact Report Appendix 403-6Promotion of worker healthHealthy BusinessOccupational Health and Safety Statement403-7Prevention and mitigation of o

274、ccupational health and safety impact directly linked by business relationshipsOccupational Health and Safety StatementCVS Health Code of ConductHuman Capital Data,p.23 2024 Impact Report Appendix403-8Workers covered by an occupational health andsafety management systemOccupational Health and Safety

275、StatementCVS Health Code of ConductHuman Capital Data,p.23 2024 Impact Report Appendix403-9Work-related injuriesOccupational Data,p.23 2024 Impact Report Appendix403-10Work-related ill healthOccupational Data,p.23 2024 Impact Report Appendix403:Occupational Health and SafetyGlobal Reporting Initiati

276、ve (GRI Index)Next Section54Table of ContentsGRI Disclosure No.GRI Disclosure Title2024 CVS Health Response3-3Management of material topicsHealthy 2030 Impact Strategy&Governance,p.4,2024 Impact Report AppendixPrioritization Assessment,p.8,2024 Impact Report AppendixStakeholder Engagement,p.9-11,202

277、4 Impact Report Appendix404-1Average hours of training per year per employeeEmployee Engagement Data,p.24,2024 Impact Report Appendix404-2Programs for upgrading employee skills andtransition assistance programsHealthy BusinessHealthy Community404-3Percentage of employees receiving regularperformance

278、 and career development reviewsConfidentiality constraints:CVS Health considers these data points confidential.404:Training&EducationGlobal Reporting Initiative (GRI Index)GRI Disclosure No.GRI Disclosure Title2024 CVS Health Response3-3Management of material topicsHealthy 2030 Impact Strategy&Gover

279、nance,p.4,2024 Impact Report AppendixPrioritization Assessment,p.8,2024 Impact Report AppendixStakeholder Engagement,p.9-11,2024 Impact Report Appendix405-1Diversity of governance bodies and employeesHuman Capital Data,p.X,2024 Impact Report AppendixDirector Qualification CriteriaDiversity,2025 Prox

280、y Statement405-2Ratio of basic salary and remuneration of womento menConfidentiality constraints:CVS Health considers these data point confidential.405:Diversity&Equal OpportunityNext Section55Table of ContentsGRI Disclosure No.GRI Disclosure Title2024 CVS Health Response3-3Management of material to

281、picsHealthy 2030 Impact Strategy&Governance,p.4,2024 Impact Report AppendixPrioritization Assessment,p.8,2024 Impact Report AppendixStakeholder Engagement,p.9-11,2024 Impact Report Appendix406-1Legal actions for anti-competitive behavior,anti-trust,and monopoly practicesWe have robust policies and a

282、venues in place for reporting grievances or violations of our Code of Conduct.The Company investigates all good faith reports of wrongdoing and handles appropriately.We do not disclose further details on incidents as this information is considered confidential.Our commitment to human rights,p.28,202

283、4 Impact Report Appendix406:Non-DiscriminationGRI Disclosure No.GRI Disclosure Title2024 CVS Health Response3-3Management of material topicsHealthy 2030 Impact Strategy&Governance,p.4,2024 Impact Report AppendixPrioritization Assessment,p.8,2024 Impact Report AppendixStakeholder Engagement,p.9-11,20

284、24 Impact Report Appendix407-1Incidents of discrimination and corrective actions takenAbout this Report,p.40-41,2024 Impact Report Appendix;Prioritization Assessment,p.8,2024 Impact Report AppendixStakeholder Engagement,p.9-11,2024 Impact Report Appendix407:Freedom of Association and Collective Barg

285、ainingGRI Disclosure No.GRI Disclosure Title2024 CVS Health Response3-3Management of material topicsHealthy 2030 Impact Strategy&Governance,p.4,2024 Impact Report AppendixPrioritization Assessment,p.8,2024 Impact Report AppendixStakeholder Engagement,p.9-11,2024 Impact Report Appendix408-1Operations

286、 and suppliers in which the right to freedom of association and collective bargaining may be at riskAll factories within scope for our Ethical Sourcing&Customs Trade Partnership Against Terrorism(CTPAT)Compliance Program are considered to have risk for the right to freedom of association and collect

287、ive bargaining to be at risk.Social Compliance Audit Summary,p.30-31,2024 Impact ReportAppendixCVS Health Code of Conduct CVS Health Human Rights Policy408:Child LaborGlobal Reporting Initiative (GRI Index)Next Section56Table of ContentsGRI Disclosure No.GRI Disclosure Title2024 CVS Health Response3

288、-3Management of material topicsHealthy 2030 Impact Strategy&Governance,p.4,2024 Impact Report AppendixPrioritization Assessment,p.8,2024 Impact Report AppendixStakeholder Engagement,p.9-11,2024 Impact Report Appendix409-1Operations and suppliers at significant risk for incidents of forced or compuls

289、ory laborAll factories within scope for our Ethical Sourcing&Customs Trade Partnership Against Terrorism(CTPAT)Compliance Program are considered to have significant risk for incidents of forced or compulsory labor.Social Compliance Audit Summary,p.30-31,2024 Impact ReportAppendixCVS Health Human Rig

290、hts Policy409:Forced or Compulsory LaborGRI Disclosure No.GRI Disclosure Title2024 CVS Health Response3-3Management of material topicsHealthy 2030 Impact Strategy&Governance,p.4,2024 Impact Report AppendixPrioritization Assessment,p.8,2024 Impact Report AppendixStakeholder Engagement,p.9-11,2024 Imp

291、act Report Appendix410-1Percentage of security personnel who havereceived formal training in the organizationshuman rights policiesAll CVS Health colleagues,members of its Board of Directors,and suppliers,are required to acknowledge receipt of the Codeof Conduct and Human Rights Policy annually.Addi

292、tionally,allcolleagues must complete an annual Code of Conduct andCompliance training.In 2024,nearly 100%of active colleaguescompleted this training.CVS Health Code of ConductCVS Health Human Rights Policy410:Security PracticesGlobal Reporting Initiative (GRI Index)GRI Disclosure No.GRI Disclosure T

293、itle2024 CVS Health Response3-3Management of material topicsHealthy 2030 Impact Strategy&Governance,p.4,2024 Impact Report AppendixPrioritization Assessment,p.8,2024 Impact Report AppendixStakeholder Engagement,p.9-11,2024 Impact Report Appendix413-1Operations with significant actual and potentialne

294、gative impacts on local communitiesCorporate Profile,p.3,2024 Impact ReportStakeholder Engagement,p.9-11,2024 Impact Report AppendixHealthy Community413:Local CommunitiesNext Section57Table of ContentsGRI Disclosure No.GRI Disclosure Title2024 CVS Health Response3-3Management of material topicsHealt

295、hy 2030 Impact Strategy&Governance,p.4,2024 Impact Report Appendix;Prioritization Assessment,p.8,2024 Impact Report AppendixStakeholder Engagement,p.9-11,2024 Impact Report Appendix414-1New suppliers that were screened using socialcriteriaAll suppliers within scope for our Ethical Sourcing&Customs T

296、rade Partnership Against Terrorism(CTPAT)Compliance Program are required to undergo risk-based audits.Social Compliance Audit Summary,p.30-31,2024 Impact Report Appendix414-2Negative social impacts in the supply chain andactions takenAll suppliers within scope for our Ethical Sourcing&Customs Trade

297、Partnership Against Terrorism(CTPAT)Compliance Program are required to undergo risk-based audits.Social Compliance Audit Summary,p.30-31,2024 Impact Report Appendix414:Training&EducationGlobal Reporting Initiative (GRI Index)GRI Disclosure No.GRI Disclosure Title2024 CVS Health Response415-1Politica

298、l contributions2025 Political Activities and Contributions Report415:Public PolicyGRI Disclosure No.GRI Disclosure Title2024 CVS Health Response3-3Management of material topicsHealthy 2030 Impact Strategy&Governance,p.4,2024 Impact Report Appendix;Prioritization Assessment,p.8,2024 Impact Report App

299、endixStakeholder Engagement,p.9-11,2024 Impact Report Appendix416-1Assessment of the health and safety impacts ofproduct and service categoriesHealthy PlanetHealthy BusinessCVS Health assess our Store Brand products through our robust quality assurance processes.This includes the factory the product

300、 is manufactured in,as well as adherence to our Restricted Substances List,Chemical Safety Policy,and Responsible Palm Oil Policy,among others.416-2Incidents of non-compliance concerning the health and safety impacts of products and servicesSocial Compliance Audit Summary,p.30-31,2024 Impact Report

301、Appendix416:Customer Health and SafetyNext Section58Table of ContentsGRI Disclosure No.GRI Disclosure Title2024 CVS Health Response3-3Management of material topicsHealthy 2030 Impact Strategy&Governance,p.4,2024 Impact Report Appendix;Prioritization Assessment,p.8,2024 Impact Report AppendixStakehol

302、der Engagement,p.9-11,2024 Impact Report Appendix417-1Requirements for product and service information and labelingHealthy PlanetHealthy BusinessTested to Be TrustedCosmetic Safety PolicyCVS Store Brand Restricted Substances ListCommitment to Responsible Marketing Practices417-2Incidents of non-comp

303、liance concerning product and service information and labelingConfidentiality constraints:CVS Health considers this information confidential417-3Incidents of non-compliance concerning marketing communicationsConfidentiality constraints:CVS Health considers this information confidential417:Marketing&

304、LabelingGlobal Reporting Initiative (GRI Index)GRI Disclosure No.GRI Disclosure Title2024 CVS Health Response3-3Management of material topicsHealthy 2030 Impact Strategy&Governance,p.4,2024 Impact Report Appendix;Prioritization Assessment,p.8,2024 Impact Report AppendixStakeholder Engagement,p.9-11,

305、2024 Impact Report Appendix418-1Substantiated complaints concerning breaches ofcustomer privacy and losses of customer dataWe publicly report breaches as required to the U.S.Department of Health and Human Services(HHS)Office of Civil Rights.See Breach Portal.Any additional information is confidentia

306、l.418:Customer PrivacyNext Section59Table of ContentsSASB IndexSASB SectorSASB IndustrySASB IndicatorTopic2024Consumer GoodsMultiline andSpecialty Retailers&DistributorsCG-MR-130a.1Total Energy10,517,024Consumer GoodsMultiline andSpecialty Retailers&DistributorsCG-MR-130a.1Proportion of power use fr

307、om renewable sources5.41%Consumer GoodsMultiline andSpecialty Retailers&DistributorsCG-MR-130a.1Proportion of power use from grid electricity94.59%Food&BeverageFood Retailers&DistributorsFB-FR-110b.3Operational energy consumed10,517,024Food&BeverageFood Retailer&DistributorsFB-FR-110a.1Fleet Fuel co

308、nsumed,percentage renewable1,018,503 GJ,2.2%Environment,Energy Consumption(Global)Next SectionSASB SectorSASB IndustrySASB IndicatorTopic2024Food&BeverageFood Retailers&DistributorsFB-FR-110b.3Gross global Scope 1 emissions from refrigerants65,538Food&BeverageFood Retailer&DistributorsFB-FR-110b.2Pe

309、rcentage of refrigerants consumed with zero ozone-depleting potential91%Food&BeverageFood Retailer&DistributorsFB-FR-110b.3Average refrigerant emissions rate53%Air Emissions from Refrigeration60Table of ContentsSASB IndexSASB SectorSASB IndustrySASB IndicatorTopic2024Consumer GoodsHousehold&Personal

310、 ProductsCG-MR-130a.1Total water withdrawn6,590,098Consumer GoodsHousehold&Personal ProductsCG-MR-130a.1Percent water withdrawn in regions with High or Extremely High Baseline Water Stress17%Consumer GoodsHousehold&Personal ProductsCG-MR-130a.1Total water consumed1,720,621Consumer GoodsHousehold&Per

311、sonal ProductsFB-FR-110b.3Percent water consumed in regions with High or Extremely High Baseline Water Stress20%Consumer GoodsHousehold&Personal ProductsFB-FR-110b.3Description of water management risks and discussion of strategies to mitigate those risksResponsible Water Use PolicyWater ManagementN

312、ext Section61Table of ContentsSASB IndexSASB SectorSASB IndustrySASB IndicatorTopic2024Health CareHealth Care DeliveryHC-DY-150a.1Total amount of medical waste(mt)619Health CareHealth Care DeliveryHC-DY-150a.1(1)Percent incinerated2%Health CareHealth Care DeliveryHC-DY-150a.1(2)Percent recycled or t

313、reated96%Health CareHealth Care DeliveryHC-DY-150a.1(3)Percent landfilled2%Health CareHealth Care DeliveryHC-DY-150a.2Total amount of hazardouspharmaceutical waste(mt)788Health CareHealth Care DeliveryHC-DY-150a.2(1)Percent incinerated84%Health CareHealth Care DeliveryHC-DY-150a.2(2)Percent recycled

314、 or treated16%Health CareHealth Care DeliveryHC-DY-150a.2(3)Percent landfilled-%Health CareHealth Care DeliveryHC-DY-150a.2Total amount of non-hazardous pharmaceutical waste(mt)230Health CareHealth Care DeliveryHC-DY-150a.2(1)Percent incinerated100%Health CareHealth Care DeliveryHC-DY-150a.2(2)Perce

315、nt recycled or treated-%Health CareHealth Care DeliveryHC-DY-150a.2(3)Percent landfilled-%Waste ManagementSASB SectorSASB IndustrySASB IndicatorTopic2024FinancialsInsuranceFN-IN-550a.3Description of approach to managing capital andliquidity-related risks associated with systemic non-insurance activi

316、ties2024 Proxy StatementSystemic Risk ManagementNext Section62Table of ContentsSASB IndexHuman CapitalSASB SectorSASB IndustrySASB IndicatorTopic2024Health CareHealth Care DeliveryHC-DY-320a.1Total recordable incident rate(TRIR)1.580Health CareHealth Care DeliveryHC-DY-320a.1Days away,restricted,or

317、transferred(DART)rateCompany-wide:0.723Retail:0.936Distribution Center:5.430Health care Delivery:0.43Employee Health&Safety*SASB SectorSASB IndustrySASB IndicatorTopic2024Health CareHealth Care DeliveryHC-DY-320a.1Physicians*Health CareHealth Care DeliveryHC-DY-320a.1(1)Voluntary turnover rate15%Hea

318、lth CareHealth Care DeliveryHC-DY-320a.1(2)Involuntary turnover rate1.4%Health CareHealth Care DeliveryHC-DY-320a.1Non-Physician health care practitionersHealth CareHealth Care DeliveryHC-DY-320a.1(1)Voluntary turnover rate19.6%Health CareHealth Care DeliveryHC-DY-320a.1(2)Involuntary turnover rate4

319、.4%Health CareHealth Care DeliveryHC-DY-320a.1All other employeesHealth CareHealth Care DeliveryHC-DY-320a.1(1)Voluntary turnover rate27.6%Health CareHealth Care DeliveryHC-DY-320a.1(2)Involuntary turnover rate5.7%Health CareHealth Care DeliveryHC-DY-320a.2Description of talent recruitment and reten

320、tion efforts for health carepractitionersHealthcare Careers SiteEmployee Recruitment,Development&Retention*This data does not include temporary labor.Temporary labor contracts are such that the companies that provide temporary labor are responsible for reporting their own injuries*Due to updates in

321、internal role categorization,the physician role group for 2024 reporting includes both patient-facing and non-patient facing physicians.Next Section63Table of ContentsSASB IndexHuman CapitalSASB SectorSASB IndustrySASB IndicatorTopic2024Consumer GoodsMultiline andSpecialist Retailers&DistributorsCG-

322、MR-310a.1Average Hourly WageAll Colleagues:$32.17Data for Oak Street Health,Signify Health,and Cordavis is unavailableLabor PracticesNext SectionConsumer GoodsMultiline andSpecialist Retailers&DistributorsCG-MR-330a.1Percentage Female57%Consumer GoodsMultiline andSpecialist Retailers&DistributorsCG-

323、MR-330a.1Percentage White*62%Consumer GoodsMultiline andSpecialist Retailers&DistributorsCG-MR-330a.1Percentage Hispanic*9%Consumer GoodsMultiline andSpecialist Retailers&DistributorsCG-MR-330a.1Percentage Black*11%Consumer GoodsMultiline andSpecialist Retailers&DistributorsCG-MR-330a.1Percentage As

324、ian*14%Consumer GoodsMultiline andSpecialist Retailers&DistributorsCG-MR-330a.1Percentage more than one ethnicity*2%Consumer GoodsMultiline andSpecialist Retailers&DistributorsCG-MR-330a.1Percentage Unknown*1%Consumer GoodsMultiline andSpecialist Retailers&DistributorsCG-MR-330a.1Percentage Female72

325、%Consumer GoodsMultiline andSpecialist Retailers&DistributorsCG-MR-330a.1Percentage White*98%ManagementAll other colleagues*U.S.colleagues only64Table of ContentsSASB IndexHuman CapitalConsumer GoodsMultiline andSpecialist Retailers&DistributorsCG-MR-310a.1Percentage Hispanic*18%Consumer GoodsMultil

326、ine andSpecialist Retailers&DistributorsCG-MR-330a.1Percentage Black*19%Consumer GoodsMultiline andSpecialist Retailers&DistributorsCG-MR-330a.1Percentage Asian*12%Consumer GoodsMultiline andSpecialist Retailers&DistributorsCG-MR-330a.1Percentage more than one ethnicity*3%Consumer GoodsMultiline and

327、Specialist Retailers&DistributorsCG-MR-330a.1Percentage Unknown*2%SASB SectorSASB IndustrySASB IndicatorTopic2024FinancialsInsuranceFN-UB-410a.1Total invested assets,by industry and asset classInvestmentsIncorporation of Environmental,Social,and Governance Factors in Investment ManagementLabor Pract

328、ices Cont.Next Section*U.S.colleagues only65Table of ContentsSASB IndexSocial CapitalSASB SectorSASB IndustrySASB IndicatorTopic2024Health CareDrug RetailersHealth Care DeliveryHC-DR-230a.1HC-DY-230a.2Description of policies and practices to secure customers protected health information(PHI)records

329、and other personally identifiableinformation(PII)Data Protection and Privacy,p.39,2023 Healthy 2030 Impact Report AppendixOur Privacy Policies can be found on our website.Consumer GoodsMultiline and Specialty Retailers&DistributorsCG-MR-230a.1Description of approach to identifying and addressing dat

330、a security risksData Protection and Privacy,p.39,2023 Healthy 2030 Impact Report AppendixData Security&PrivacySASB SectorSASB IndustrySASB IndicatorTopic2024Health CareHealth Care DeliveryHC-DY-260a.1Description of policies and practices to manage the number of prescriptions issued for controlled su

331、bstancesCVS Health has made a commitment to help address the misuse of prescription opioids by designing programs and collaborating with community leaders,policymakers,lawenforcement,health care professionals and others to increase community-based educational programs related to opioid misuse,create

332、 safe prescription drug disposal sites,expand access to life-saving antidotes and advocate for targeted and effective policies,locally and nationally.More information on our commitments to address the misuse of opioids is available on our website.Management of Controlled SubstancesNext Section66Tabl

333、e of ContentsSASB IndexSocial CapitalHealth CareDrug RetailersHC-DR-260b.1Description of policies and practices to prevent prescription dispensing errorsCVS Pharmacy has contracted with a patient safety organization,or“PSO,”federally certified under the Patient Safety and Quality Improvement Act of 2005 including with Enterprise Patient Safety Organization(“EPSO”)since 2014.Weve learned that culti